AstraZeneca PLC (AZN)
USD 64.64
(-3.78%)
USD 64.64
(-3.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 10.34 Billion | 9.8 Billion | 5.96 Billion | 4.79 Billion | 2.96 Billion | 2.61 Billion |
| Net Income | 6.89 Billion | 2.5 Billion | -265 Million | 3.91 Billion | 1.54 Billion | 1.99 Billion |
| Depreciation & Amortization | 4.93 Billion | 5.48 Billion | 6.53 Billion | 3.14 Billion | 3.76 Billion | 3.75 Billion |
| Deferred income taxes | - | -619 Million | -615 Million | -277 Million | -259 Million | - |
| Stock-based compensation | 579 Million | 619 Million | 615 Million | 277 Million | 259 Million | 219 Million |
| Change in working capital | 300 Million | 3.75 Billion | 2.02 Billion | 361 Million | -346 Million | -639 Million |
| Other non-cash items | -1.78 Billion | -1.93 Billion | -2.32 Billion | -2.62 Billion | -1.99 Billion | -2.48 Billion |
| Investing Cash Flow | -4.06 Billion | -2.96 Billion | -11.05 Billion | -285 Million | -657 Million | 963 Million |
| Investments in PPE | -3.77 Billion | -2.57 Billion | -2.2 Billion | -2.6 Billion | -2.46 Billion | -1.37 Billion |
| Acquisitions | -1.17 Billion | -1.06 Billion | -9.43 Billion | -830 Million | -783 Million | -536 Million |
| Investment purchases | -136 Million | -159 Million | -184 Million | -119 Million | -13 Million | -102 Million |
| Sales/Maturities of investments | 129 Million | 42 Million | 105 Million | 2.12 Billion | 212 Million | 429 Million |
| Other Investing Activities | 900 Million | 789 Million | 654 Million | 1.14 Billion | 2.38 Billion | 2.54 Billion |
| Financing Cash Flow | -6.56 Billion | -6.82 Billion | 3.64 Billion | -2.2 Billion | -1.76 Billion | -2.04 Billion |
| Debt repayment | -4.94 Billion | -1.27 Billion | -4.75 Billion | -1.6 Billion | -1.18 Billion | -1.49 Billion |
| Dividends payments | -4.48 Billion | -4.36 Billion | -3.85 Billion | -3.57 Billion | -3.59 Billion | -3.48 Billion |
| Common Stock Repurchased | 3.7 Billion | -920 Million | 12.41 Billion | 3.04 Billion | - | 2.97 Billion |
| Common Stock Issuance | 33 Million | 29 Million | 29 Million | 30 Million | 3.52 Billion | 34 Million |
| Other Financing Activities | -886 Million | -297 Million | -178 Million | -101 Million | 3.01 Billion | -67 Million |
| Accounts receivables | -1.42 Billion | -1.34 Billion | -961 Million | -739 Million | -898 Million | -523 Million |
| Accounts payables | 2.39 Billion | 1.16 Billion | 1.4 Billion | 1.72 Billion | 868 Million | -103 Million |
| Inventory | -669 Million | 3.94 Billion | 1.57 Billion | -621 Million | -316 Million | -13 Million |
| Other working capital | 2.39 Billion | - | - | - | - | -626 Million |
| Cash at beginning of period | 5.98 Billion | 6.03 Billion | 7.54 Billion | 5.22 Billion | 4.67 Billion | 3.17 Billion |
| Cash at end of period | 5.63 Billion | 5.98 Billion | 6.03 Billion | 7.54 Billion | 5.22 Billion | 4.67 Billion |
| Capital Expenditure | -3.77 Billion | -2.57 Billion | -2.2 Billion | -2.6 Billion | -2.46 Billion | -1.37 Billion |
| Effect of forex changes on cash | -60 Million | -80 Million | -62 Million | 12 Million | 5 Million | -38 Million |
| Net cash flow / Change in cash | -346 Million | -55 Million | -1.5 Billion | 2.32 Billion | 552 Million | 1.49 Billion |
| Free Cash Flow | 6.56 Billion | 7.23 Billion | 3.76 Billion | 2.19 Billion | 509 Million | 1.24 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.92 Billion | 2.17 Billion | 897 Million | 6.89 Billion | 1.65 Billion | 2.08 Billion |
| Depreciation & Amortization | 1.27 Billion | 1.25 Billion | 874 Million | 4.93 Billion | 1.28 Billion | 1.27 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 579 Million | 579 Million | - | - |
| Change in working capital | -129 Million | -455 Million | 150 Million | 300 Million | 897 Million | -989 Million |
| Other non-cash items | 2.67 Billion | 2.11 Billion | 459 Million | -1.78 Billion | -717 Million | -657 Million |
| Investing Cash Flow | -2.98 Billion | -2.5 Billion | -1.07 Billion | -4.06 Billion | -1.22 Billion | -520 Million |
| Investments in PPE | -668 Million | -1.6 Billion | -946 Million | -3.77 Billion | -879 Million | -483 Million |
| Acquisitions | -2.29 Billion | -895 Million | -296 Million | -1.17 Billion | -273 Million | -184 Million |
| Investment purchases | -109 Million | -97.99 Million | -15 Million | -136 Million | -95 Million | -26 Million |
| Sales/Maturities of investments | 89 Million | 17 Million | 97 Million | 129 Million | -68 Million | 81 Million |
| Other Investing Activities | -193 Million | 74.99 Million | 83 Million | 900 Million | 94 Million | 92 Million |
| Financing Cash Flow | -1.22 Billion | 2.02 Billion | -291 Million | -6.56 Billion | -2.72 Billion | -1.51 Billion |
| Debt repayment | -1.13 Billion | -5.97 Billion | -287 Million | -4.94 Billion | -1.24 Billion | -1.4 Billion |
| Dividends payments | -17 Million | -3.03 Billion | -2 Million | -4.48 Billion | -1.41 Billion | -22 Million |
| Common Stock Repurchased | -833 Million | -833 Million | -867 Million | 3.7 Billion | 840 Million | - |
| Common Stock Issuance | 5 Million | 5.99 Million | 21 Million | 33 Million | 4 Million | 4 Million |
| Other Financing Activities | 833 Million | -7.99 Million | 844 Million | -886 Million | -913 Million | -97 Million |
| Accounts receivables | - | - | -1.42 Billion | -1.42 Billion | - | - |
| Accounts payables | - | - | - | 2.39 Billion | - | - |
| Inventory | - | - | -669 Million | -669 Million | - | - |
| Other working capital | -129 Million | -455 Million | -150 Million | - | 897 Million | -989 Million |
| Cash at beginning of period | 7.84 Billion | 5.84 Billion | 4.61 Billion | 5.98 Billion | 5.47 Billion | 5.82 Billion |
| Cash at end of period | 6.91 Billion | 7.84 Billion | 5.63 Billion | 5.63 Billion | 4.61 Billion | 5.47 Billion |
| Capital Expenditure | -668 Million | -1.6 Billion | -946 Million | -3.77 Billion | -879 Million | -483 Million |
| Effect of forex changes on cash | -6 Million | -46 Million | 6 Million | -60 Million | -19 Million | -36 Million |
| Net cash flow / Change in cash | -925 Million | 2 Billion | 1.01 Billion | -346 Million | -852 Million | -357 Million |
| Free Cash Flow | 2.53 Billion | 974 Million | 1.43 Billion | 6.56 Billion | 2.23 Billion | 1.23 Billion |
229000
300664
2149
DUELL
NDTP
9556